Stocks / CRL vs EHC

CRL vs EHC: Which Stock Is the Better Buy?

Charles River Laboratories International, Inc. and Encompass Health Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

CRL is the larger company ($10.8B vs $10.1B). On the fundamentals, EHC grows revenue faster (10.7% vs 6.5%); EHC earns a higher net margin (9.5% vs -3.6%); EHC has the stronger return on equity (23.2% vs -4.6%). On the filings, EHC carries fewer potential red flags (0 vs 1). Full numbers below — the stronger figure on each row is in green.

AI verdict — CRL vs EHC, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

	Charles River Laboratories International, Inc. (CRL)	Encompass Health Corporation (EHC)
Market cap	$10.8B	$10.1B
Revenue (latest FY)	$4.02B	$5.94B
Net income (latest FY)	$-144.34M	$566.20M
Revenue growth (5y CAGR)	6.5%	10.7%
Net margin	-3.6%	9.5%
Return on equity	-4.6%	23.2%
P/E ratio	—	17.5
Dividend yield	—	0.7%
Profitable years (of last 10)	9	10
Positive free cash flow	Yes	Yes

Compare with another company:

See the full CRL vs EHC breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open CRL's full financials → Open EHC's full financials →

More comparisons

BMRN vs CRL EHC vs MOH CRL vs MDGL EHC vs HSIC CRL vs GMED ARWR vs EHC CRL vs ICLR EHC vs SMMT

Frequently asked questions

Which is bigger, CRL or EHC?

Charles River Laboratories International, Inc. is larger by market capitalization — $10.8B versus $10.1B.

Which grows faster, CRL or EHC?

Over the last five fiscal years, Encompass Health Corporation grew revenue faster — 10.7%/yr versus 6.5%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

Quality compounders →

CRL fundamentals → · EHC fundamentals → · All 1,500+ companies → · Free screener →